MILLENNIUM MANAGEMENT LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 44 filers reported holding CIDARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$134,685
+25701.7%
119,190
-82.7%
0.00%
Q4 2022$522
-99.0%
689,917
+724.1%
0.00%
Q3 2022$53,000
+112.0%
83,716
+62.1%
0.00%
Q2 2022$25,000
-34.2%
51,654
+14.4%
0.00%
Q1 2022$38,000
-65.1%
45,153
-47.4%
0.00%
Q4 2021$109,000
-84.7%
85,782
-73.0%
0.00%
Q3 2021$713,000
-39.2%
318,149
-45.2%
0.00%
-100.0%
Q2 2021$1,173,000
+590.0%
580,793
+810.8%
0.00%
Q1 2021$170,000
-57.4%
63,770
-68.0%
0.00%
Q4 2020$399,000
+200.0%
199,354
+271.4%
0.00%
Q1 2020$133,000
-63.5%
53,674
-43.3%
0.00%
Q4 2019$364,000
+14.5%
94,687
-49.9%
0.00%
Q2 2019$318,000
-47.3%
189,143
-16.9%
0.00%
-100.0%
Q1 2019$603,000
+21.8%
227,516
+7.9%
0.00%0.0%
Q4 2018$495,000
-74.3%
210,817
-51.8%
0.00%
-50.0%
Q3 2018$1,923,000
-48.8%
437,053
-39.5%
0.00%
-60.0%
Q2 2018$3,759,000
+22.9%
722,826
-5.5%
0.01%
+25.0%
Q1 2018$3,059,000
-24.2%
764,663
+28.8%
0.00%
-33.3%
Q4 2017$4,036,000
-17.6%
593,563
-1.8%
0.01%
-14.3%
Q3 2017$4,897,000
+10.8%
604,590
+2.6%
0.01%
-12.5%
Q2 2017$4,419,000
+163.2%
589,243
+173.7%
0.01%
+166.7%
Q1 2017$1,679,000
+145.5%
215,284
+227.2%
0.00%
+200.0%
Q4 2016$684,000
-9.6%
65,789
+10.6%
0.00%0.0%
Q3 2015$757,000
-54.0%
59,508
-49.3%
0.00%
-66.7%
Q2 2015$1,646,000117,4090.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,356,813$3,189,0004.48%
Omega Fund Management, LLC 1,508,794$3,546,0002.63%
ALETHEA CAPITAL MANAGEMENT, LLC 482,357$1,134,0001.65%
Opaleye Management Inc. 1,200,000$2,820,0001.05%
BVF INC/IL 2,904,684$6,826,0000.89%
FRAZIER MANAGEMENT LLC 1,312,258$3,084,0000.80%
Monashee Investment Management LLC 480,851$1,130,0000.76%
Aisling Capital LLC 1,021,148$2,400,0000.68%
Trellus Management Company, LLC 94,143$221,0000.50%
Prosight Management, LP 245,764$578,0000.30%
View complete list of CIDARA THERAPEUTICS INC shareholders